DIRS.INFO The most relevant business & tech news

The rate of weight loss with the experimental pill, called amycretin, appears to be more rapid than what’s seen for other drugs. “It’s roughly double the weight loss rate seen with current GLP-1 agonists and approaching procedural or surgical-level outcomes,” said Dr. Christopher McGowan, a gastroenterologist who runs a weight loss clinic in North Carolina. McGowan said that while the weight loss was significant, he still has concerns about how fast people lost weight. “While losing weight is seemingly the end goal, how that weight is lost matters,” he said. Spratt said she would like to know how much of the weight loss came from fat compared with muscle.

Persons: “, ”, Christopher McGowan, ” Dr, Susan Spratt, Spratt, haven’t, Martin Lange, Lange, McGowan, ” McGowan Organizations: Novo Nordisk, European Association for, Diabetes, Population Health Management, Duke Health Locations: Novo, Spain, North Carolina, semaglutide, Wegovy, It’s

☆ These drugmakers are catching up to Eli Lilly and Novo Nordisk in weight loss treatments
▼ + stars: | 2024-07-28 | by ( Christina Cheddar Berk | In | ) www.cnbc.com time to read: +6 min

With billions at stake, that's pretty much been a guarantee facing the current market leaders, Eli Lilly and Novo Nordisk , from the start. Their updates are likely to be joined by others in the coming months even as today's incumbents develop their own next-generation weight loss treatments. Other analysts have also grown more optimistic about the future of weight loss treatments. Orforglipron, a once-a-day oral GLP-1 drug that Lilly is working on, had shown a 3% weight loss at 4 weeks. The company is also exploring whether the weight loss treatment could be given only once a month.

Persons: Eli Lilly, drugmakers Roche, Lilly, Denmark's, Trung Huynh, Huynh, Rajesh Kumar, Kumar, Novo, Roche, Roche ADRs, Justin Zelin, Zelin, Viking's, HSBC's Kumar, Novo aren't, —, Nick Wells Organizations: Novo Nordisk, Viking Therapeutics, UBS, HSBC Global Research, Carmot Therapeutics, Food and Drug Administration, Viking, European Association for, Diabetes, Pfizer, Amgen, Therapeutics Locations: Swiss, Novo, San Antonio, Spain

☆ As EV sales surge and cars get heavier, parking garages will have to change
▼ + stars: | 2023-10-03 | by ( Anmar Frangoul | ) www.cnbc.com time to read: +6 min

Parking garages (known as multistory car parks in the U.K.) are one area where the proliferation of EVs and bigger vehicles is expected to have a major impact. In a statement, it said the reason behind the weight increase was "due to electric and hybrid batteries and the size of cars increasing." The cumulative load of these vehicles in parking garages could present some challenges in certain circumstances. "Because what we want is the public to maintain confidence in our car parks and structural engineers." The statement also said the "rise of e-mobility … helps us mitigate climate change and brings new questions, including weight and the impact on car parks."

Persons: Peter Titmuss, Chris Whapples, Whapples, you've, it's, Dana Kenedy Organizations: Getty, Engineers, CNBC, EV, European Commission, European Association for Electromobility, Istock Locations: England, London, Brussels

☆ EVs are billed as the future. But a potential skills gap is sparking concerns about cost and safety
▼ + stars: | 2023-02-27 | by ( Anmar Frangoul | ) www.cnbc.com time to read: +5 min

Thanks to growing concerns about emissions from road-based transportation, several big economies are gearing up for another huge change: the mass rollout of electric vehicles. There are concerns, however, that a skills gap may emerge in the near future, creating a big headache for both the automotive sector and drivers. "Aligned to Auto Trader Insight predictions, this suggests the skills gap — when there won't be enough technicians to service the electrified vehicle parc — will appear in 2029," it added. "But fundamentally, electric vehicles are totally different to internal combustion engine vehicles," he said. 'Chipping away at the skills gap'

☆ Drinking tea may lower the risk of diabetes, heart disease and death, mounting research shows
▼ + stars: | 2022-09-17 | by ( Aria Bendix | Aria Bendix Is The Breaking Health Reporter For Nbc News Digital. | ) www.nbcnews.com time to read: +4 min

Mounting evidence suggests that drinking several cups of tea per day has numerous health benefits, including lowering one's risk of heart disease, stroke, diabetes and overall mortality. The risk of developing diabetes went down by 1% for each additional daily cup. The study also revealed an association between drinking multiple cups of tea and a lower risk of coronary heart disease and stroke. Antioxidants in tea could reduce inflammationThe health benefits of drinking tea may have to do with polyphenols, compounds found naturally in plants that provide antioxidants. Inoue-Choi's study did not, however, find any association between drinking tea and a reduced risk of death from cancer.

Search resuls for: "European Association for"

5 mentions found